Worse Morning Energy Profiles Are Associated with Significant Levels of Stress and Decrements in Resilience in Patients Receiving Chemotherapy
- PMID: 39164158
- DOI: 10.1016/j.soncn.2024.151718
Worse Morning Energy Profiles Are Associated with Significant Levels of Stress and Decrements in Resilience in Patients Receiving Chemotherapy
Abstract
Objectives: Evidence suggests that lower levels of morning energy are associated with higher levels of stress and lower levels of resilience in patients receiving chemotherapy. Study purposes were to identify subgroups of patients with distinct morning energy profiles; evaluate for differences among the profiles in demographic and clinical characteristics, as well as measures of stress, resilience, and coping.
Methods: A total of 1,343 outpatients receiving chemotherapy completed a demographic questionnaire and measures of global, cancer-related, and cumulative life stress, and resilience at study enrollment. Morning energy was assessed using the Lee Fatigue Scale at six time points over two cycles of chemotherapy. Latent profile analysis was used to identify subgroups of patients with distinct morning energy profiles. Differences among the subgroups were evaluated using parametric and nonparametric tests.
Results: Three morning energy profiles were identified (i.e., High (17.3%), Low (60.3%), Very Low (22.4%)). Compared to High class, the other two morning energy classes were less likely to be employed; had a lower functional status and a higher comorbidity burden; and were more likely to self-report depression and back pain. For all three types of stress, significant differences were found among the three classes with scores that demonstrated a dose response effect (i.e., High < Low < Very Low; as decrements in morning energy increased, stress scores increased). Compared to High class, Very Low class reported higher rates of physical and sexual abuse. The resilience scores exhibited a dose response effect as well (i.e., High > Low > Very Low). Patients with the two worst energy profiles reported a higher use of disengagement coping strategies.
Conclusions: Findings highlight the complex relationships among decrements in morning energy, various types of stress, resilience, and coping in patients undergoing chemotherapy.
Implications for nursing practice: Clinicians need to assess for stress and adverse childhood experiences to develop individualized management plans to increase patients' energy levels.
Keywords: Cancer; Chemotherapy; Coping; Energy; Resilience; Stress.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflicts of interest to declare.
Similar articles
-
Higher Levels of Multiple Types of Stress Are Associated With Worse State Anxiety and Morning Fatigue Profiles in Patients Receiving Chemotherapy.Cancer Nurs. 2025 Mar-Apr 01;48(2):E75-E89. doi: 10.1097/NCC.0000000000001304. Epub 2024 Jan 23. Cancer Nurs. 2025. PMID: 38259094
-
Stress Exposures Contribute to Worse Joint Morning and Evening Fatigue Profiles in Patients With Cancer During Chemotherapy.Oncol Nurs Forum. 2024 Feb 19;51(2):89-106. doi: 10.1188/24.ONF.89-106. Oncol Nurs Forum. 2024. PMID: 38442280
-
Higher levels of stress and different coping strategies are associated with greater morning and evening fatigue severity in oncology patients receiving chemotherapy.Support Care Cancer. 2020 Oct;28(10):4697-4706. doi: 10.1007/s00520-020-05303-5. Epub 2020 Jan 20. Support Care Cancer. 2020. PMID: 31956947 Free PMC article.
-
Morning Fatigue Severity Profiles in Oncology Outpatients Receiving Chemotherapy.Cancer Nurs. 2019 Sep/Oct;42(5):355-364. doi: 10.1097/NCC.0000000000000626. Cancer Nurs. 2019. PMID: 30024437 Free PMC article.
-
Distinct Co-occurring Morning and Evening Fatigue Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.Cancer Nurs. 2024 Jan-Feb 01;47(1):E28-E37. doi: 10.1097/NCC.0000000000001148. Epub 2022 Dec 11. Cancer Nurs. 2024. PMID: 36076314 Free PMC article.